Peptide record

TPDB23164

Antibacterial Anticancer Toxicity standard
23 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB23164
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia
standard
No
A 23-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from Peptipedia, with an available 3D structural model.
Sequence
LTVSPWYGCGMPFSTGKRIMLGE
Physicochemical Analysis
C114H176N28O31S3
ANDQH
G
2531.00
8.88
2
1
9
+1
-0.68
0.152
63.48
Mammalian: 5.5 hour Yeast: 3 min E.coli: 2 min
6990
276.18
6
Residue Composition
number
0
A
1
R
0
N
0
D
1
C
1
E
0
Q
4
G
0
H
1
I
2
L
1
K
2
M
1
F
2
P
2
S
2
T
1
W
1
Y
1
V
Amino Acid Distribution
A: 0 R: 1 N: 0 D: 0 C: 1 E: 1 Q: 0 G: 4 H: 0 I: 1 L: 2 K: 1 M: 2 F: 1 P: 2 S: 2 T: 2 W: 1 Y: 1 V: 1
Chemical Descriptors
23
C114H176N28O31S3
2531.00
8.88
+1
-0.68
0.152
Evidence Records 4 records
Evidence 1 Activity

Activity

0% Killing
Toxicity
50 µM
Cytotoxic
0% Killing | 50 | µM | target cell: Chinese hamster ovary cells CHO-K1

Target

Chinese hamster ovary cells CHO-K1

Source & Reference

NA
DBAASP
Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy. | Oncotarget | 2016
Evidence 2 Activity

Activity

0% Killing
Toxicity
50 µM
Cytotoxic
0% Killing | 50 | µM | target cell: Human foreskin fibroblasts (HFF)

Target

Human foreskin fibroblasts (HFF)

Source & Reference

NA
DBAASP
Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy. | Oncotarget | 2016
Evidence 3 Activity

Activity

0% Killing
Toxicity
50 µM
Cytotoxic
0% Killing | 50 | µM | target cell: Human fibroblasts WI-38

Target

Human fibroblasts WI-38

Source & Reference

NA
DBAASP
Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy. | Oncotarget | 2016
Evidence 4 Activity

Activity

Toxicity
Hemolytic Cytotoxic
Hemolytic_activity: Not available | Cytotoxicity: CHO-K1: 0%Killing=50 µM HFF: 0%Killing=50 µM WI-38: 0%Killing=50 µM

Target

erythrocytes

Source & Reference

NA
DRAMP
Oncotarget. 2016 Feb 2 7(5):5483-94.